Central Nervous System Bacterial Infections
Central Nervous System Bacterial Infections
Explore linked clinical trials. Standard reference: MESH:M032821139 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Fatigue, Infections, Muscular Disorders, Atrophic, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Treponema infectious disease, X-linked disease, bacterial infectious disease, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, neurosyphilis, spinal cord disorder, spirochaetales infections, syphilis, tabes dorsalis | Recruiting | Phase 2 | 2026-10-08 | NCT07766980 | |
| Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis. | Bacterial Infections and Mycoses, Borrelia infectious disease, Central Nervous System Bacterial Infections, Infections, Lyme Neuroborreliosis, Lyme disease, bacterial infectious disease, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, nervous system disorder, spirochaetales infections, tick-borne infectious disease, vector-borne disease | Recruiting | Not applicable | 2026-10-02 | NCT05641116 | |
| B-PaLMZ for TB Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, disease arising from reactivation of latent virus, gram-positive bacterial infections, latent tuberculosis infection, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 2 | 2026-09-30 | NCT07227779 | |
| Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Active, not recruiting | Phase 2 | 2026-09-28 | NCT05087056 | |
| Exploring the Combination of Intracalvariosseous and Intravenous Antibiotics for Moderate to Severe Bacterial Meningitis | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, meningitis, nervous system disorder | Not yet recruiting | Not applicable | 2026-09-17 | NCT07826351 | |
| Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study. | Bacterial Infections and Mycoses, Borrelia infectious disease, Central Nervous System Bacterial Infections, Infections, Lyme Neuroborreliosis, Lyme disease, bacterial infectious disease, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, nervous system disorder, spirochaetales infections, tick-borne infectious disease, vector-borne disease | Not yet recruiting | Phase 4 | 2026-08-27 | NCT07230028 | |
| Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal. | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Central Nervous System Fungal Infections, Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, fungal infectious disease, fungal meningitis, meningitis, nervous system disorder, viral infection of central nervous system, viral infectious disease, viral meningitis | Recruiting | Not applicable | 2026-08-21 | NCT07432113 | |
| Acute Treatment and Long-term Assessment of Adult Infectious Meningitis | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Central Nervous System Fungal Infections, Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, fungal infectious disease, fungal meningitis, meningitis, nervous system disorder, viral infection of central nervous system, viral infectious disease, viral meningitis | Recruiting | Not stated | 2026-08-13 | NCT07027475 | |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Active, not recruiting | Phase 3 | 2026-08-10 | NCT07505888 | |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Recruiting | Phase 3 | 2026-08-10 | NCT07505836 | |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Recruiting | Phase 3 | 2026-08-10 | NCT07505823 | |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Recruiting | Phase 3 | 2026-08-10 | NCT07505810 | |
| A Clinical Trial of the ACYW135 Group Meningococcal Polysaccharide-Conjugated Vaccine (CRM197 Vector) | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Not yet recruiting | Not stated | 2026-08-03 | NCT07743411 | |
| Metagenomic Analysis of the Pharynx in High Risk Partners | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Genital Diseases, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, Urogenital Diseases, bacterial infectious disease, bacterial meningitis, bacterial sexually transmitted disease, central nervous system disorder, central nervous system infectious disorder, gonorrhea, gram-negative bacterial infections, infectious disease, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder, sexually transmitted disease | Not yet recruiting | Not stated | 2026-06-30 | NCT07671014 | |
| Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 3 | 2026-06-24 | NCT04145258 | |
| Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 2 | 2026-06-02 | NCT05383742 | |
| Adjunctive Doxycycline for Central Nervous System Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, gram-positive bacterial infections, meningeal tuberculosis, meningitis, meningoencephalitis, mycobacterial infectious disease, nervous system disorder, tuberculosis, viral infection of central nervous system | Recruiting | Phase 2 | 2026-06-01 | NCT06446245 | |
| Vasodilator and Exercise Study for DMD (VASO-REx) | Aneurysm, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Infections, Muscular Disorders, Atrophic, Treponema infectious disease, X-linked disease, bacterial infectious disease, cardiovascular disorder, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, neurosyphilis, spinal cord disorder, spirochaetales infections, syphilis, tabes dorsalis, vascular disorder | Recruiting | Phase 2 | 2026-05-15 | NCT06290713 | |
| A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults | Bacterial Infections and Mycoses, Borrelia infectious disease, Central Nervous System Bacterial Infections, Infections, Lyme Neuroborreliosis, Lyme disease, bacterial infectious disease, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, nervous system disorder, spirochaetales infections, tick-borne infectious disease, vector-borne disease | Active, not recruiting | Phase 3 | 2026-05-06 | NCT07226882 | |
| A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Active, not recruiting | Phase 4 | 2026-04-06 | NCT06113198 | |
| Febrile Infants Swedish Study | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Male Urogenital Diseases, Neuroinflammatory Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, Urogenital Diseases, bacterial infectious disease, bacterial infectious disease with sepsis, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, disease, meningitis, nervous system disorder, urinary system disorder, urinary tract infection | Recruiting | Not stated | 2026-04-02 | NCT07134751 | |
| Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, meningitis, nervous system disorder | Not yet recruiting | Not applicable | 2026-03-27 | NCT07495150 | |
| Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Active, not recruiting | Phase 4 | 2026-03-04 | NCT05935176 | |
| Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Not yet recruiting | Phase 2 | 2026-03-03 | NCT07350174 | |
| Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Cerebral Ventriculitis, Infections, Infectious Ventriculitis, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, meningitis, nervous system disorder, viral infection of central nervous system | Not yet recruiting | Phase 2 | 2026-02-24 | NCT07431307 |